Create a narrative

Fennec Pharmaceuticals Community

NasdaqCM:FENC Community

1 Narratives written by author
0 Comments on narratives written by author
2 Fair Values set on narratives written by author

Create a narrative

Fennec Pharmaceuticals

AN

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

Expansion Into AYA Segment And International Partnerships Will Drive PEDMARK's Growth In 2025

Key Takeaways Expansion into the adolescent and young adult market for PEDMARK is expected to drive significant revenue growth post-2025 with favorable reimbursement trends. Strategic partnerships in Europe and potential access changes through medical compendia could enhance revenue and earnings growth significantly by mid-2025.

US$12.60

FV

50.0% undervalued

31.31%

Revenue growth p.a.

0

0

1

3 days ago